• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

167.2300 USD 1.9200 1.16%

As of 20:04:04 ET on 10/24/2014.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 165.3200 High - Low: 167.5000 - 164.6000 Primary Exchange: NYSE Arca
Volume: 517,375 52-Week Range: 114.1200 - 172.5240 Beta vs SPSIBITR: 1.0001

ETF Chart for XBI

No chart data available.
  • XBI:US 167.2300
  • 1D
  • 1M
  • 1Y
165.3100
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2014-10-24) 167.1220
Assets (M) (on 2014-10-24) 1,303.5510
Shares out (M) 7.80
Market Cap (M) 1,304.39
% Premium 0.06
Average 52-Week % Premium -0.0122
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.5628
Dividend Yield (ttm) 0.93%

Performance for XBI

1-Month +4.91% 1-Year +35.59%
3-Month +12.94% 3-Year +36.56%
Year To Date +29.70% 5-Year +27.92%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 10/24/2014
Name Position Value % of Total
Agios Pharmaceuticals Inc 360,999 29,100,129 2.234%
NewLink Genetics Corp 581,686 22,383,277 1.718%
AMAG Pharmaceuticals Inc 625,198 20,812,841 1.597%
Alnylam Pharmaceuticals Inc 220,056 20,650,055 1.585%
Repligen Corp 854,679 20,606,311 1.582%
Merrimack Pharmaceuticals Inc 2,196,053 20,566,036 1.578%
Clovis Oncology Inc 346,492 19,258,025 1.478%
BioMarin Pharmaceutical Inc 234,757 19,022,360 1.460%
Vertex Pharmaceuticals Inc 171,686 18,870,008 1.448%
Alexion Pharmaceuticals Inc 98,087 18,664,975 1.433%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil